Etiracetam

Etiracetam is a nootropic drug that is part of the racetam family. It is structurally similar to piracetam, the first nootropic drug of its kind, but with a higher potency. Etiracetam is known for its cognitive enhancing effects, particularly in the areas of memory, concentration, and mood.

History

Etiracetam was first synthesized in the 1970s as part of a series of compounds designed to improve cognitive function. It was developed by the same team that created piracetam, led by Dr. Corneliu E. Giurgea. The goal was to create a more potent version of piracetam, and etiracetam was one of the successful results.

Pharmacology

Like other racetams, etiracetam works by modulating the release of neurotransmitters in the brain. It is believed to enhance the function of the neurotransmitter acetylcholine, which plays a key role in memory and learning processes. It may also increase the density of acetylcholine receptors in the brain.

Clinical Use

Etiracetam is used in some countries as a prescription medication for conditions such as Alzheimer's disease, dementia, and other cognitive impairments. It is also used off-label by healthy individuals seeking to improve their cognitive performance.

Side Effects

Common side effects of etiracetam include headache, nausea, and irritability. These are usually mild and temporary. More serious side effects are rare, but can include allergic reactions and mood changes.

Legal Status

The legal status of etiracetam varies by country. In some countries, it is available as a prescription medication, while in others it is sold as a dietary supplement. In some jurisdictions, it is considered a controlled substance and is illegal to buy or sell without a prescription.

See Also

• Piracetam
• Nootropics
• Neurotransmitters
• Acetylcholine

‎